These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


191 related items for PubMed ID: 6273131

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Characterization of alpha 2-adrenergic receptors of calf retina membranes by [3H]-rauwolscine and [3H]-RX 781094 binding.
    Convents A, De Backer JP, Vauquelin G.
    Biochem Pharmacol; 1987 Aug 01; 36(15):2497-503. PubMed ID: 3038126
    [Abstract] [Full Text] [Related]

  • 23. Characterization of the human platelet alpha-adrenergic receptor. Correlation of [3H]dihydroergocryptine binding with aggregation and adenylate cyclase inhibition.
    Alexander RW, Cooper B, Handin RI.
    J Clin Invest; 1978 May 01; 61(5):1136-44. PubMed ID: 207726
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. High affinity binding of 3H rauwolscine and 3H RX781094 to alpha 2 adrenergic receptors and non-stereoselective sites in human and rabbit brain cortex membranes.
    Convents A, Convents D, De Backer JP, De Keyser J, Vauquelin G.
    Biochem Pharmacol; 1989 Feb 01; 38(3):455-63. PubMed ID: 2563652
    [Abstract] [Full Text] [Related]

  • 26. Decreased alpha-adrenergic receptors in newborn platelets: cause of abnormal response to epinephrine.
    Corby DG, O'Barr TP.
    Dev Pharmacol Ther; 1981 Feb 01; 2(4):215-25. PubMed ID: 6266790
    [Abstract] [Full Text] [Related]

  • 27. Characterization of alpha 2-adrenergic receptors in human platelets by binding of a radioactive ligand [3H]yohimbine.
    Mukherjee A.
    Biochim Biophys Acta; 1981 Aug 17; 676(2):148-54. PubMed ID: 6114754
    [Abstract] [Full Text] [Related]

  • 28. Different affinity states of alpha-1 adrenergic receptors defined by agonists and antagonists in bovine aorta plasma membranes.
    Jagadeesh G, Deth RC.
    J Pharmacol Exp Ther; 1987 Nov 17; 243(2):430-6. PubMed ID: 2890755
    [Abstract] [Full Text] [Related]

  • 29. Characterization of alpha 1-adrenergic receptor subtypes in rat brain: a reevaluation of [3H]WB4104 and [3H]prazosin binding.
    Morrow AL, Creese I.
    Mol Pharmacol; 1986 Apr 17; 29(4):321-30. PubMed ID: 3010073
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Adrenergic receptors in human liver plasma membranes: predominance of beta 2- and alpha 1-receptor subtypes.
    Kawai Y, Powell A, Arinze IJ.
    J Clin Endocrinol Metab; 1986 May 17; 62(5):827-32. PubMed ID: 3007555
    [Abstract] [Full Text] [Related]

  • 32. Dihydroergocryptine: a "pseudo-irreversible" alpha-adrenergic antagonist in the guinea pig vas deferens.
    Wilberding CA, Marks BH.
    Res Commun Chem Pathol Pharmacol; 1981 Mar 17; 31(3):387-401. PubMed ID: 6265988
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Binding of [3H]-prazosin and [3H]-dihydroergocryptine to rat cardiac alpha-adrenoceptors.
    Guicheney P, Meyer P.
    Br J Pharmacol; 1981 May 17; 73(1):33-9. PubMed ID: 6269682
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Characterization of the alpha 1-adrenergic receptor subtype in a smooth muscle cell line.
    Cornett LE, Norris JS.
    J Biol Chem; 1982 Jan 25; 257(2):694-7. PubMed ID: 6119313
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Subtype specificity of alpha-adrenergic receptors in rat heart.
    Williams RS, Dukes DF, Lefkowitz RJ.
    J Cardiovasc Pharmacol; 1981 Jan 25; 3(3):522-31. PubMed ID: 6168833
    [Abstract] [Full Text] [Related]

  • 40. Renal alpha-1 and alpha-2 adrenergic receptors: biochemical and pharmacological correlations.
    Schmitz JM, Graham RM, Sagalowsky A, Pettinger WA.
    J Pharmacol Exp Ther; 1981 Nov 25; 219(2):400-6. PubMed ID: 6270306
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 10.